Roos RAC - Search Results

1

Cognitive decline in Huntington's disease expansion gene carriers.

Baake V, Reijntjes RHAM, Dumas EM, Thompson JC; REGISTRY Investigators of the European Huntington's Disease Network; Roos RAC. Baake V, et al. Among authors: roos rac. Cortex. 2017 Oct;95:51-62. doi: 10.1016/j.cortex.2017.07.017. Epub 2017 Aug 3. Cortex. 2017. PMID: 28843844

2

Cognitive and motor functioning in gene carriers for Huntington's disease: a baseline study.

Witjes-Ané MN, Vegter-van der Vlis M, van Vugt JP, Lanser JB, Hermans J, Zwinderman AH, van Ommen GJ, Roos RA. Witjes-Ané MN, et al. J Neuropsychiatry Clin Neurosci. 2003 Winter;15(1):7-16. doi: 10.1176/jnp.15.1.7. J Neuropsychiatry Clin Neurosci. 2003. PMID: 12556566

3

Therapeutic options for Huntington's disease.

Grimbergen YA, Roos RA. Grimbergen YA, et al. Curr Opin Investig Drugs. 2003 Jan;4(1):51-4. Curr Opin Investig Drugs. 2003. PMID: 12625029 Review.

4

Objective assessment of motor slowness in Huntington's disease: clinical correlates and 2-year follow-up.

van Vugt JP, Piet KK, Vink LJ, Siesling S, Zwinderman AH, Middelkoop HA, Roos RA. van Vugt JP, et al. Mov Disord. 2004 Mar;19(3):285-97. doi: 10.1002/mds.10718. Mov Disord. 2004. PMID: 15022182

5

Assessing genetic effects in survival data by correlating martingale residuals with an application to age at onset of Huntington disease.

Wintrebert CM, Zwinderman AH, Maat-Kievit A, Roos RA, van Houwelingen HC. Wintrebert CM, et al. Stat Med. 2006 Sep 30;25(18):3190-200. doi: 10.1002/sim.2245. Stat Med. 2006. PMID: 16416406

6

Memory activation reveals abnormal EEG in preclinical Huntington's disease.

van der Hiele K, Jurgens CK, Vein AA, Reijntjes RH, Witjes-Ané MN, Roos RA, van Dijk G, Middelkoop HA. van der Hiele K, et al. Mov Disord. 2007 Apr 15;22(5):690-5. doi: 10.1002/mds.21390. Mov Disord. 2007. PMID: 17266047

7

Longitudinal evaluation of "presymptomatic" carriers of Huntington's disease.

Witjes-Ané MN, Mertens B, van Vugt JP, Bachoud-Lévi AC, van Ommen GJ, Roos RA. Witjes-Ané MN, et al. J Neuropsychiatry Clin Neurosci. 2007 Summer;19(3):310-7. doi: 10.1176/jnp.2007.19.3.310. J Neuropsychiatry Clin Neurosci. 2007. PMID: 17827417

8

Basal ganglia volume and clinical correlates in 'preclinical' Huntington's disease.

Jurgens CK, van de Wiel L, van Es AC, Grimbergen YM, Witjes-Ané MN, van der Grond J, Middelkoop HA, Roos RA. Jurgens CK, et al. J Neurol. 2008 Nov;255(11):1785-91. doi: 10.1007/s00415-008-0050-4. Epub 2008 Dec 8. J Neurol. 2008. PMID: 19156490

9

Increased hypothalamic-pituitary-adrenal axis activity in Huntington's disease.

Aziz NA, Pijl H, Frölich M, van der Graaf AW, Roelfsema F, Roos RA. Aziz NA, et al. J Clin Endocrinol Metab. 2009 Apr;94(4):1223-8. doi: 10.1210/jc.2008-2543. Epub 2009 Jan 27. J Clin Endocrinol Metab. 2009. PMID: 19174491

10

Leptin secretion rate increases with higher CAG repeat number in Huntington's disease patients.

Aziz NA, Pijl H, Frölich M, van der Graaf AW, Roelfsema F, Roos RA. Aziz NA, et al. Clin Endocrinol (Oxf). 2010 Aug;73(2):206-11. doi: 10.1111/j.1365-2265.2009.03661.x. Epub 2009 Jun 22. Clin Endocrinol (Oxf). 2010. PMID: 19548952

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

274 results

Search Page

Filters